Evidence map›Paper›PMID 23233451›Full record

ArticleMicrobiologyOpen2012

A novel regulator RcdA of the csgD gene encoding the master regulator of biofilm formation in Escherichia coli.

Tomohiro Shimada, Yasunori Katayama, Shuichi Kawakita, Hiroshi Ogasawara, Masahiro Nakano, Kaneyoshi Yamamoto, Akira Ishihama

Abstract read
In one paragraph

Article in MicrobiologyOpen, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. CsgI (YccT) Is a Novel Inhibitor of Curli Fimbriae Formation inInternational journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Journal of biological research (Thessalonike, Greece) · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Curli biogenesis: order out of disorder.Biochimica et biophysica acta · 2014
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tomohiro ShimadaDepartment of Frontier Bioscience and Research Center for Micro-Nano Technology, Hosei University, Koganei, Tokyo, 184-8584, Japan.
Yasunori Katayama
Shuichi Kawakita
Hiroshi Ogasawara
Masahiro Nakano
Kaneyoshi Yamamoto
Akira Ishihama

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The FixJ/LuxR family transcription factor CsgD is a master regulator of biofilm formation in Escherichia coli. Previously, we identified more than 10 transcription factors that participate in regulation of the csgD promoter. After genomic SELEX screening of regulation targets, an uncharacterized TetR-type transcription factor YbjK was found to be involved in regulation of the csgD promoter. In addition, a number of stress-response genes were found to be under the direct control of YbjK. Taken together, we propose to rename it to RcdA (regulator of csgD). One unique feature of RcdA is its mode of DNA binding. Gel shift, DNase-I footprinting, and atomic force microscopic (AFM) analyses indicated that RcdA is a DNA-binding protein with a high level of cooperativity, with which it covers the entire surface of probe DNA through protein-protein interaction and moreover it induces the formation of aggregates of DNA-RcdA complexes.

Indexed as

BiofilmsBlotting, NorthernDNA-Binding ProteinsDNA FootprintingElectrophoretic Mobility Shift AssayEscherichia coliEscherichia coli ProteinsMicroscopy, Atomic ForcePromoter Regions, GeneticSELEX Aptamer TechniqueTrans-ActivatorsTranscription, GeneticCsgD protein, E coliDNA-Binding ProteinsEscherichia coli ProteinsTrans-Activators

Identifiers

PMID23233451
PMCPMC3535384

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.